Market Watch
Glaxo chief Witty says ready to ramp up play PDF Print E-mail
Deal Watch
Tuesday, 09 March 2010 00:00

Global pharma giant GlaxoSmithKline (GSK) is open to making acquisitions in India, Andrew Witty, chief executive officer said on Monday.

Read more... [Glaxo chief Witty says ready to ramp up play]
 
Merck-Millipore pharma integration may take 6 mths PDF Print E-mail
Deal Watch
Tuesday, 09 March 2010 00:00

The acquisition by Merck KGaA, the world’s oldest pharmaceutical company, of US-based life sciences company Millipore Corporation, would create a business worth close to Rs 900 crore in India for the German drug and chemical major. Further, the acquisition will enable Merck to access new markets in India for bio-pharma and bio-processing solutions and analytical tools for research and development, said analysts.

Read more... [Merck-Millipore pharma integration may take 6 mths]
 
Strides to acquire Aspen's Brazilian facility for $75 mn PDF Print E-mail
Deal Watch
Friday, 05 March 2010 00:00

Pharma firm Strides Arcolab today said it has entered into an agreement with South Africa-based Aspen to acquire the latters facility in Brazil for $75 million (nearly Rs. 343 crore).

Read more... [Strides to acquire Aspen's Brazilian facility for $75 mn]
 
Valeant enters pact with Spear Pharma to commercialize Refissa PDF Print E-mail
Deal Watch
Wednesday, 03 March 2010 00:00

Valeant Pharmaceuticals International has entered into an agreement with Spear Pharmaceuticals, Inc. for rights to commercialize Refissa, a prescription-based topical tretinoin cream used to diminish fine wrinkles and fade irregular pigmentation due to sun damage.

Read more... [Valeant enters pact with Spear Pharma to commercialize Refissa]
 
«StartPrev12345678910NextEnd»

Page 1 of 51
Banner
pharmaquest-ezine-logo
Letters and responses
Banner